PLD vs TERN · P/E 27, rev $8.79B vs $6.12B cap
Prologis Inc (PLD) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PLD currently screens at market cap $100.23B and trailing P/E 26.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PLD and TERN stock pages for the full models.
Not investment advice.